Actively Recruiting
Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment
Led by Shaikh Zayed Hospital, Lahore · Updated on 2026-05-13
86
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Fibromyalgia is a complex widespread pain disorder. OBJECTIVES To evaluate the effectiveness of oral magnesium supplementation in reducing symptom severity among fibromyalgia patients who have not responded to standard treatment, using validated scoring systems such as the Fibromyalgia Impact Questionnaire Revised (FIQR).
CONDITIONS
Official Title
Effectiveness of Oral Magnesium Supplementation in Fibromyalgia Patients Not Responding to Standard Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with fibromyalgia according to American College of Rheumatology 2016 criteria
- Age between 18 and 65 years
- Not responding to conventional treatment (amitriptyline, duloxetine, pregabalin) for at least 8 weeks
- Provided informed consent to participate in the study
You will not qualify if you...
- Have renal impairment
- Pregnant or breastfeeding women
- Currently taking magnesium or other mineral supplements
- Known inflammatory arthritis or other chronic pain syndromes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shaikh Zayed Hospital, Lahore
Lahore, Punjab Province, Pakistan, 45000
Actively Recruiting
Research Team
M
Masooma Hashmat, FCPS
CONTACT
A
Ayesha Humayun, FCPS, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here